Kevin Sun
2020 - DermTech
In 2020, Kevin Sun earned a total compensation of $2.7M as Chief Financial Officer at DermTech.
Compensation breakdown
Non-Equity Incentive Plan | $69,956 |
---|---|
Option Awards | $491,307 |
Salary | $307,500 |
Stock Awards | $1,803,281 |
Other | $696 |
Total | $2,672,740 |
Sun received $1.8M in stock awards, accounting for 67% of the total pay in 2020.
Sun also received $70K in non-equity incentive plan, $491.3K in option awards, $307.5K in salary and $696 in other compensation.
Rankings
In 2020, Kevin Sun's compensation ranked 4,294th out of 13,090 executives tracked by ExecPay. In other words, Sun earned more than 67.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 4,294 out of 13,090 | 67th |
Division Services | 926 out of 2,338 | 60th |
Major group Health Services | 97 out of 252 | 62nd |
Industry group Medical And Dental Laboratories | 30 out of 73 | 59th |
Industry Medical Laboratories | 30 out of 73 | 59th |
Source: SEC filing on April 16, 2021.
Sun's colleagues
We found four more compensation records of executives who worked with Kevin Sun at DermTech in 2020.